Avalyn Pharma Inc. (AVLN)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch AVLN
See up to 3 months of AVLN. The 7-day demo opens the 1M and 3M ranges and puts AVLN on your watchlist.
Start 7-day demoLatest AVLN insider trades
About Avalyn Pharma Inc. (AVLN)
Avalyn Pharma Inc. is an SEC registrant, filing under CIK 0001540171, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. Its offering priced on 30 April 2026 and it trades on NASDAQ.
AVLN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 31,182 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AVLN insider transactions (Form 4)
4515 Form 4 filings on record, the earliest from May 1, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert J. Meyer - Director | Grant or award | Stock Option (Right to Buy) | 31,182 | $0.00 | - | |
| Novo Holdings A/S | Other | Voting Common Stock | 3,327,734 | - footnote F1 | - | |
| Novo Holdings A/S | Other | Series A Preferred Stock | 18,000,000 | $0.00 | - | |
| Novo Holdings A/S | Other | Series B Preferred Stock | 1,986,369 | $0.00 | - | |
| Novo Holdings A/S | Open-market purchase | Voting Common Stock | 555,555 | $18.00 | $10.00M | |
| Novo Holdings A/S | Other | Series C-1 Preferred Stock | 25,899,284 | $0.00 | - | |
| Novo Holdings A/S | Other | Series C-2 Preferred Stock | 5,587,603 | $0.00 | - | |
| Novo Holdings A/S | Other | Series D Preferred Stock | 12,558,081 | $0.00 | - | |
| ||||||
| FMR LLC | Other | Common Stock | 727,585 | - footnote F1 | - | |
| FMR LLC | Other | Common Stock | 80,291 | - footnote F1 | - | |
| FMR LLC | Other | Common Stock | 872,868 | - footnote F1 | - | |
| FMR LLC | Other | Common Stock | 225,843 | - footnote F1 | - | |
| FMR LLC | Other | Common Stock | 377,948 | - footnote F1 | - | |
| FMR LLC | Other | Series A Preferred Stock | 727,585 | - footnote F1 | - | |
| FMR LLC | Other | Series B Preferred Stock | 80,291 | - footnote F1 | - | |
| FMR LLC | Other | Series C-1 Preferred Stock | 872,868 | - footnote F1 | - | |
| FMR LLC | Other | Series C-2 Preferred Stock | 225,843 | - footnote F1 | - | |
| FMR LLC | Other | Series D Preferred Stock | 377,948 | - footnote F1 | - | |
| ||||||
| Adam H. Golden - Officer | Grant or award | Stock Option (Right to Buy) | 254,891 | $0.00 | - | |
| Jill Carroll | Other | Common Stock | 1,419,298 | - footnote F1 | - | |
| Jill Carroll | Other | Common Stock | 489,486 | - footnote F3 | - | |
| Jill Carroll | Open-market purchase | Common Stock | 277,778 | $18.00 | $5.00M | |
| Jill Carroll | Other | Series C-1 Convertible Preferred Stock | 27,309,719 | - footnote F1 | - | |
| Jill Carroll | Other | Series D Convertible Preferred Stock | 9,418,561 | - footnote F3 | - | |
| ||||||
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Convertible Preferred Stock | 9,418,560 | - footnote F3 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 1,419,298 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 489,486 | - footnote F3 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 489,486 | - footnote F3 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market purchase | Common Stock | 277,778 | $18.00 | $5.00M | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 354,824 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market purchase | Common Stock | 277,777 | $18.00 | $5.00M | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series C-1 Convertible Preferred Stock | 27,309,719 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Convertible Preferred Stock | 9,418,561 | - footnote F3 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series C-1 Convertible Preferred Stock | 6,827,429 | - footnote F1 | - | |
| ||||||
 Jon Congleton | Grant or award | Stock Option (Right to Buy) | 26,978 | $0.00 | - | |
 Heather D. Turner | Grant or award | Stock Option (Right to Buy) | 26,978 | $0.00 | - | |
 Melissa Rhodes - Officer | Grant or award | Stock Option (Right to Buy) | 211,975 | $0.00 | - | |
 Douglas R. Carlson - Officer | Grant or award | Stock Option (Right to Buy) | 211,975 | $0.00 | - | |
| Kate Haviland | Grant or award | Stock Option (Right to Buy) | 26,978 | $0.00 | - | |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Other | Common Stock | 1,275,486 | - footnote F1 | - | |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Other | Series C-1 Convertible Preferred Stock | 20,482,289 | $0.00 | - | |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Other | Series D Convertible Preferred Stock | 4,060,259 | $0.00 | - | |
| ||||||
 Howard Lazarus - Officer | Grant or award | Stock Option (Right to Buy) | 211,975 | $0.00 | - | |
| Erin Lavelle | Grant or award | Stock Option (Right to Buy) | 26,978 | $0.00 | - | |
 Lyn Baranowski - Officer | Grant or award | Stock Option (Right to Buy) | 501,033 | $0.00 | - | |
Item 5.02
Item 2.02, 9.01
Item 1.01, 9.01
Item 7.01
AVLN insider trading FAQ
What is the latest insider trade for AVLN?
Avalyn Pharma Inc. (AVLN) had 1 insider filing in the last 90 days, with the most recent on 2026-09-17. The full record for AVLN runs to 15 Form 4 filings, the earliest from 2026-05-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AVLN stock?
No insider purchases of AVLN were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling AVLN stock?
No insider sales of AVLN were filed in the last 90 days.
Where can I see AVLN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AVLN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert J. Meyer view on EDGAR
- - Novo Holdings A/S view on EDGAR
- - FMR LLC view on EDGAR
- - Adam H. Golden view on EDGAR
- - Jill Carroll view on EDGAR
- - SR ONE CAPITAL MANAGEMENT, LLC view on EDGAR
- - Jon Congleton view on EDGAR
- - Heather D. Turner view on EDGAR
- - Melissa Rhodes view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AVLN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AVLN with a 7-day demo
- AVLN on your watchlist
- Every AVLN Form 4 filing on record
- Up to 3 months of AVLN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
